ESAs Boost Stroke Risk, But Not Mortality
Meta-analysis also reveals an increased risk of vascular access thrombosis, but no increased likelihood of end-stage renal disease.
Meta-analysis also reveals an increased risk of vascular access thrombosis, but no increased likelihood of end-stage renal disease.
Taking dutasteride for two years cut risk of PSA doubling by 66% among prostate cancer patients with PSA relapse after radical treatment.
In 2009, Wyoming Medical Center in Casper, Wyo., instituted a safety program designed to reduce errors causing serious harm to patients.
The case involved a woman who went to a New Hampshire emergency department complaining of back pain.
Providing financial incentives is gaining in popularity, but little research has been done to ascertain whether this approach has the intended effect.
In a pilot study, the medication increased urine output and residual glomerular filtration rate.
If a lupus patient has never had renal disease, pregnancy, in and of itself, is not likely to increase that risk.
Dual kidney transplants (DKT), in which transplant patients receive both of a donor’s kidneys, have outcomes similar to those of recipients of expanded criteria donor (ECD) kidneys.
Clinicians are prescribing less erythropoietin and more intravenous iron for anemic hemodialysis patients after the introduction of a prospective payment system (PPS) for dialysis services (“bundling”) and changes to ESA drug labels.
Hyponatremia is a relatively common electrolyte abnormality in the general U.S. adult population.